Please assess the completion status of the following clinical trial:

Trial Title: Transvaginal Tape (TVT) Secur Versus TVT Randomised Controlled Trial (RCT)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women with stress incontinence, defined as leaking with increased abdominal pressure~* Eligible for both types of surgery~Exclusion Criteria:~Women who:~* Have vaginal prolapse requiring surgical repair~* Have had previous incontinence surgery~* Have overactive bladder or incontinence is caused only by bladder overflow~* Intend to have further children~* Have Alzheimer's or Parkinson's disease, progressive neurological disease such as multiple sclerosis, or are immunocompromised~* Are unable to understand English~* Will be unavailable for follow-up

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- TVT Secur surgical device (Type: EXPERIMENTAL): Single incision tape device
- TVT surgical device (Type: ACTIVE_COMPARATOR): Usual care retropubic tape device

Based on this trial design, predict the completion outcome and termination type (if applicable).